AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology.
Cippitelli A, Wu J, Gaiolini KA, Mercatelli D, Schoch J, Gorman M, Ramirez A, Ciccocioppo R, Khroyan TV, Yasuda D, Zaveri NT, Pascual C, Xie XS, Toll L.
Cippitelli A, et al. Among authors: toll l.
Br J Pharmacol. 2015 Apr;172(7):1834-45. doi: 10.1111/bph.13034. Epub 2015 Jan 23.
Br J Pharmacol. 2015.
PMID: 25440006
Free PMC article.